RIGEL PHARMACEUTICALS INC (RIGL) has 9 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 1 sales totalling $88K. Most recent filing: Sept. 3, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 3, 2026 filed Sept. 1, 2026 | Santos David A EVP, Chief Commercial Officer | $41,515 | 874 | −1% | No | |
|
|
||||||
| Sept. 3, 2026 filed Sept. 1, 2026 | Schorno Dean L EVP & Chief Financial Officer | — | +3,672 | +30% | No | |
|
|
||||||
| July 10, 2026 filed July 8, 2026 | HANNAH ALISON L. EVP, Chief Medical Officer | $0 | 24,400 | +230% | No | |
|
|
||||||
| June 24, 2026 filed June 22, 2026 | Ali-Jackson Kamil Director | −$87,500 | 2,500 | −20% | Yes | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | Furey Raymond J. EVP, GC, CCO & Corp Sec | $0 | 7,394 | 0% | No | |
|
|
||||||
Showing the 5 most recent of 9 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free